INNPFOTC Markets OTCQB
InnoCan Pharma Corporation
$2.40
ListedNov 27, 2020
SectorConsumer Defensive
IndustryHousehold & Personal Products
CountryCanada
Employees-
StateAB| CityCalgary| Address1015, 926 – 5 Avenue SW| Phone403-777-1519
InnoCan Pharma Corporation operates as a pharmaceutical technology company in United States, Canada, Europe, and internationally. The company operates through two segments, Online sales and Other Operations. The company develops a cannabidiol (CBD)-loaded liposome drug delivery platform (CBD-LPT), which is in the preclinical trial phase to treat chronic pain management for human and veterinary health sectors. It also offers a pain-relieving topical composition, as well as compositions for the treatment of hemorrhoid, psoriasis of the scalp, vaginal atrophy, and diabetic symptoms. The company is also involved in development, manufacture, and marketing of cosmetic products. InnoCan Pharma Corporation was founded in 2017 and is headquartered in Calgary, Canada.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
0.0
?
Div. Rate
$0.00
?
Div. Yield
0.00%
?
Payout Ratio
0.00%
?
Max Consec. Div. Years
5 years
?
Longest Consec. Div.
5 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.37
?
Div. Growth Rate
25.00%
?
Score
74

Dividend History

Historical dividend payments by ex-dividend date.

May 15, 2026
$ 0.3700
Feb 13, 2026
$ 0.3700
Nov 14, 2025
$ 0.3700
Aug 15, 2025
$ 0.3700
May 16, 2025
$ 0.3700
Feb 14, 2025
$ 0.3700
Nov 15, 2024
$ 0.3700
Aug 16, 2024
$ 0.3700
May 16, 2024
$ 0.3700
Feb 14, 2024
$ 0.3700
Nov 15, 2023
$ 0.3700
Aug 16, 2023
$ 0.3700
May 16, 2023
$ 0.3700
Feb 13, 2023
$ 0.3700
Nov 15, 2022
$ 0.3700
Aug 16, 2022
$ 0.3700
May 16, 2022
$ 0.3700
Feb 11, 2022
$ 0.3700
Nov 15, 2021
$ 0.4400

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!